Approved Research This page provides a searchable list of all research protocols that have been reviewed and approved by the Uganda National Council for Science and Technology(UNCST).
Search By Approval Date:
Clear Filter Total: 6,010
Name Title Nationality Approval Date Expiry Date Field of Science/Classification Trial Type Research Type  
Shelley Jones
ID:
Women to Women Research for Economic Empowerment in Uganda: A Participatory Action Research Project
REFNo: SS710ES

The goal of this project is to engage women in Uganda in conducting research that investigates successful community-based, women-led entrepreneurial initiatives in order to inventory, analyze, and report on best practices and lessons learned that will contribute to knowledge that can be accessed by other women who are interested in entrepreneurship. The objectives are to support the participants to 1) develop research skills that will enable them to gain information, knowledge, and insights into how to develop thriving, sustainable initiatives that provide sufficient income to attain and sustain a reasonable standard of living; 2) create and disseminate knowledge around issues directly concerned with women’s empowerment through entrepreneurship
Canada 2021-06-21 2024-06-21 Social Science and Humanities Non-Clinical Trial Non-degree Award
Sam Ononge
ID: UNCST-2020-R000328
A PILOT STUDY TO EVALUATE THE PRELIMINARY SAFETY OF THE WEKEBERE SYSTEM FOR THE EARLY DETECTION OF PREGNANCY COMPLICATIONS.
REFNo: HS1025ES

To determine the safety of using the wekebere system in monitoring fetal wellbeing.
To determine the acceptability of the wekebere system among the expectant mothers and clinical staff.

Uganda 2021-06-18 2024-06-18 Medical and Health Sciences Non-Clinical Trial Non-degree Award
Irene Andia Biraro Rebecca
ID: UNCST-2019-R001475
A Randomized Double Blind Placebo Controlled Trial of Rifapentine and Isoniazid for Prevention of Tuberculosis in People with Diabetes.
REFNo: HS1112ES

Primary objective:
To assess the efficacy of preventive therapy with a 12-week course of rifapentine and isoniazid (3HP) against the development of probable or definite TB disease over 24 months in people with Diabetes Mellitus (DM) who are latent TB infection (LTBI) test positive.
Secondary objectives:
• To assess the efficacy of 3HP against the development of possible, probable or definite TB disease over 24-40 months in people with DM who are latent tuberculosis infection test positive
• To compare the proportions who complete treatment between arms
• To compare the occurrence of adverse events between arms
• To compare the rate of TB or death between arms
• To compare the overall mortality rate between arms
• To explore the efficacy of 3HP against development of probable or definite TB in those who are LTBI test positive, across the following sub-groups, separately: study site (n=3); age groups; duration of DM; level of glycaemic control (baseline HbA1C) and body mass index (BMI).
• To assess the efficacy of 3HP against development of probable or definite TB, in two restricted analyses: TST positive and IGRA positive participants.
• To carry out sub-studies including i) an economic modelling and cost effectiveness study, ii) a cohort study of those who are IGRA and TST negative a baseline, iii) a cross-sectional study of HIV and TB prevalence and DM phenotype, (iv) evaluation of point-of care (POC) testing for LTBI, and computer-assisted X-ray, (v) a public health study of patient management, and v) future genetic studies.

Uganda 2021-06-18 2024-06-18 Medical and Health Sciences Clinical Trial Non-degree Award
Elisabeth Vodicka
ID:
Evaluating the ongoing costs and operational context of national HPV vaccine delivery in Uganda
REFNo: HS1358ES

Identify the HPV vaccination program cost drivers and opportunities and challenges for improving cost efficiency.,Evaluate the quality of existing HPV vaccination program performance data.,Understand the contextual factors of the delivery approach for the HPV vaccination program.,Estimate the ongoing costs to deliver HPV vaccines for the health system and supporting platforms (e.g., department of education). ,Evaluate the annual ongoing financial and economic delivery costs for HPV vaccination in Uganda. ,
USA 2021-06-18 2024-06-18 Medical and Health Sciences Non-Clinical Trial Non-degree Award
FRANCIS TUMWESIGYE N/A
ID:
GENDER INCLUSION AND SERVICE PROVISION BY CORE SECURITY AGENCIES IN UGANDA. A CASE OF UGANDA POLICE IN KAMPALA METROPOLITAN AREA.
REFNo: SS779ES

TO EXAMINE THE EFFECTS OF WOMEN PARTICIPATION ON PROVISION OF SERVICES BY THE UGANDA POLICE FORCE.,TO FIND OUT THE BENEFITS OF WOMEN EMPOWERMENT ON PROVISION OF SERVICES BY THE UGANDA POLICE FORCE.,TO ASSESS THE IMPACTS OF WOMEN REPRESENTATION ON EFFECTIVE PROVISION OF SERVICES IN THE UGANDA POLICE FORCE.,TO EXAMINE THE EFFECTS OF GENDER EQUALITY ON EFFECTIVE PROVISION OF SERVICES BY THE UGANDA POLICE FORCE.,THE STUDY OUGHT TO EXAMINE THE EFFECTS OF GENDER INCLUSION AND PROVISION OF SERVICES BY THE UGANDA POLICE FORCE IN THE CONTEPOLARY POLICING.,
Uganda 2021-06-18 2024-06-18 Social Science and Humanities Non-Clinical Trial Degree Award
View Sort By:

"A prosperous Science and Technology Led Ugandan Society."